Researchers Identify Hidden Side Effects from GLP-1 Weight Loss and Diabetes Drugs
A recent breakthrough study has identified previously hidden side effects stemming from GLP-1 weight loss and diabetes drugs like semaglutide and tirzepatide. The study, based on an analysis of over 400,000 posts on the social media platform Reddit spanning more than five years, was published in Nature Health.
The findings highlight two main types of symptoms: reproductive and temperature-related. Users reported experiencing irregular menstrual cycles, heavy bleeding, intermenstrual bleeding, hot flashes, fever, and chills – all not described during clinical trials. Fatigue also emerged as a persistent symptom among users.
According to Sharath Chandra Guntuku, Research Associate Professor in Computer and Information Science at Penn Engineering and the study’s senior author, “Some of the side effects we found, like nausea, are well known, and that shows that the method is picking up a real signal.”
The underreported symptoms, which came from patients themselves, unprompted, could potentially be paid attention to by clinicians. While the study’s findings are limited by the specific demographics of Reddit, highlighting younger American males, the side effects reported by this group align closely with established clinical data for semaglutide and tirzepatide.
Roughly 44% of users reported experiencing at least one known side effect, gastrointestinal issues being the most frequent complaint. Lyle H. Ungar, PhD, a professor at Penn Engineering, notes that while clinical trials are excellent at flagging high-risk safety concerns, they often overlook the day-to-day symptoms that bother patients the most.
“Online patient communities work a lot like a neighborhood grapevine. People who are living with these medications are swapping notes with each other in real time, sharing experiences that rarely make it into a doctor’s office visit or an official report,” Ungar added.
Researchers hope these findings will encourage experts and drug developers to take into account symptoms posted online by users. The authors of the study aim to expand their research beyond Reddit to delve further into unreported symptoms.


